Aardvark Therapeutics, Inc. financial statements
Aardvark Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | 10-K |
| Net income | −USD 57.59M | 10-K |
| Cash and equivalents | USD 47.05M | 10-Q |
| Total debt | USD 441K | EODHD |
Aardvark Therapeutics, Inc. financials on 6ix · Aardvark Therapeutics, Inc. on 6ix